Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cytotoxicity, Leaching, and Structural Conformation of Invisalign Aligners with Different Cleaning Methods
NCT06503029Phase 4Not yet recruiting
- Sponsor
- Riyadh Elm University
- Start
- Jul 2024
- Primary completion
- Jan 2025
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial (4 arms), sponsored by Riyadh Elm University. Primary endpoints: Cytotoxicity, Leaching and 1 more. Planned start Jul 2024; status: not yet recruiting.
Beyond the preview
Go deeper on NCT06503029.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06503029.